Abstract
The intellectual property literature concerning novel anti-Helicobacter agents for the period of 1998 and 1999 is reviewed. The majority of the citations described herein involve the synthesis and evaluation of new compounds and the identification of new vaccine candidate antigens and their formulation. Despite the large number of novel anti-H. pylori agents under development, no significant advances have been made in H. pylori therapy or vaccination in this period.